Company news
Ondine Biomedical, Inc. news in 2024
Ondine Biomedical, Inc.'s news releases, calls and decks from 2024, newest first.
Ondine recruits first patient for US Phase 3 trial
December 30, 2024
Ondine commencing US Phase 3 clinical trial
December 17, 2024
Director Holdings
November 22, 2024
Notification of major holdings
November 18, 2024
Final Result of Fundraise & TVR
November 15, 2024
Updated Result of Fundraise
November 14, 2024
Update on Private Placement and Placing
November 11, 2024
Result of Fundraise
November 1, 2024
Related Party Transaction
October 30, 2024
Ondine continues commercial growth
October 28, 2024
King’s College Hospital to run Steriwave pilot
October 23, 2024
Steriwave receives UAE Regulatory Approval
October 18, 2024
Ondine Biomedical Reports Robust Growth in H1 2024
September 30, 2024
Collaboration advances Steriwave for ICU Market
September 25, 2024
Ondine secures C$5 million financing
September 24, 2024
Mölnlycke® and Ondine Join Forces Against HAIs
September 23, 2024
Ondine announces Board Changes
September 16, 2024
Steriwave in British Columbia Health Authorities
August 23, 2024
Leeds Teaching Hospital NHS Trust to use Steriwave
August 6, 2024
Result of AGM and Voting Results
June 28, 2024
Steriwave now available through NHS Supply Chain
June 21, 2024
2023 Full Year Results and Annual Report
June 7, 2024
Notice of AGM and Directorate Change
June 6, 2024
Notice of Results, Investor Presentation, and AGM
May 28, 2024
ECDC report shows rising HAIs and antibiotic use
May 10, 2024
Further Result of Fundraising
May 8, 2024
Result of Fundraising
May 3, 2024
Related Party Transactions
May 2, 2024
New study confirms nose is key source of infection
April 25, 2024
Corporate and Trading Update
April 24, 2024
Steriwave in first Australian hospital
April 22, 2024
32% Fewer SSIs After Steriwave Replaced Mupirocin
April 15, 2024
Steriwave authorized for use by HCA UK
April 10, 2024
Entry into ICU market expands revenue potential
April 4, 2024
Appointment of Interim Chief Financial Officer
March 28, 2024
First commercial adoption of Steriwave by the NHS
March 25, 2024
Steriwave study shows 77% drop in antibiotic use
March 21, 2024
Replacement: Steriwave deploying in 8 new sites
March 15, 2024
Ondine starts first UK health economics study
March 5, 2024
Microbiome research supports use of Steriwave
January 31, 2024
Ondine unveils new research at SPIE Photonics West
January 26, 2024
Ondine Biomedical - Appointment of new Chief Financial Officer
January 17, 2024
Appointment of new Chief Financial Officer
January 16, 2024